Search Results

built numerous technologies in gene synthesis, DNA information storage, gene editing, and large-scale multiplexed assays.

Badr recounted Badr's Journey, Multiplexing Assays, and Collaboration Badr shared his learning process Yamina emphasized the potential of multiplexing assays in expanding the scope of scientific exploration

assay.” – Tom Sakmar After exploring several screening techniques, the lab adopted the Luminex bead-based assay , which allowed simultaneous detection of multiple GPCR-RAMP interactions. assays. focusing on a single receptor, students now gravitate toward platforms , biosensors , and data-rich assays Keyword Cloud GPCR-RAMP interactions , multiplex assays , GPCR research community , Dr.

Tom Sakmar and Ilana Kotliar about how their lab developed: A multiplexed Luminex assay to screen hundreds Tom Sakmar and Ilana Kotliar about how their lab developed: A multiplexed Luminex assay to screen hundreds

big.Ep.167 of the Dr.GPCR Podcast with Tom Sakmar & Ilana Kotliar is about scaling GPCR research with multiplexing big.Ep.167 of the Dr.GPCR Podcast with Tom Sakmar & Ilana Kotliar is about scaling GPCR research with multiplexing From Pipettes to Platforms: The Evolution of GPCR Research The first time Michelle ran a cyclic AMP assay

technologies are shedding light on GPCR dynamics directly in cells, offering exciting possibilities for multiplexing technologies are shedding light on GPCR dynamics directly in cells, offering exciting possibilities for multiplexing

Get custom, fast, and functional ligands backed by real scientists solving real assay problems. 🧪 “We We solve assay problems.” – Dr. Maria Majellaro, CSO, Celtarys Listen to Ep. 168 now and meet your new assay partner 😉 ✳️ https://www.ecosystem.drgpcr.com Get custom, fast, and functional ligands backed by real scientists solving real assay problems. 🧪 “We We solve assay problems.” – Dr.

By using signalling assays, radioligand binding assay, and microscopy, Gaidarov et al. suggested that By using signalling assays, radioligand binding assay, and microscopy, Gaidarov et al. suggested that

Trinquet discusses the science and story behind pH Sense, Revvity’s innovative GPCR internalization assay GPCR Podcast Strategic Partners From Rare Earth Probes to Internalization Assays: The pHSense Story with Eric Trinquet What does it take to design a breakthrough GPCR assay—from idea to industrial impact? With a career spanning two decades at the intersection of fluorescence chemistry, functional assays, What shifted the team’s strategy from traditional calcium assays to IP1 accumulation—and why it mattered

Check out the development of a NanoBRET assay platform to detect intracellular ligands for the chemokine Check out the development of a NanoBRET assay platform to detect intracellular ligands for the chemokine ➡️ https://www.ecosystem.drgpcr.com/methods-and-updates-in-gpcr-research/development-of-a-nanobret-assay-platform-to-detect-intracellular-ligands-for-the-chemokine-receptors-ccr6

Home → Flash News → Exploring the combination of molecular simulation, pharmacological assays, and NMR , 2024 Category GPCR Weekly News Exploring the combination of molecular simulation, pharmacological assays

✳️Celtarys is ready to support your assay development. Get to know more: Celtarys Research | Dr. ✳️Celtarys is ready to support your assay development. Get to know more: Celtarys Research | Dr.

GPCR to support assay development worldwide. GPCR to support assay development worldwide.

Michelle Halls reveals how organized GPCR signaling drives assay innovation and new therapeutic insights This conversation is especially valuable for scientists developing functional assays, fluorescence-based What early cyclic AMP assays revealed about spatial signaling long before high-content technologies existed development and GPCR research. ⸻ Why It Might Hit Home If you’ve ever: Faced unexpected assay behavior Get behind-the-scenes conversations, advanced assay development strategies, and practical GPCR tools

biotech company specializing in fluorescent ligand technologies and real-time, non-radioactive GPCR assays biotech company specializing in fluorescent ligand technologies and real-time, non-radioactive GPCR assays From Pipettes to Platforms: The Evolution of GPCR Research The first time Michelle ran a cyclic AMP assay

Gain deep insights into GPCR drug candidates and learn the critical assays and techniques required to Gain deep insights into GPCR drug candidates and learn the critical assays and techniques required to

He also discussed the evolution of the field, from biochemical radioligand binding assays to cell-based functional assays, and the influence of Terry Kenakin and chemical programs on his later work. They discussed strategies for analyzing large compound screening data, emphasizing robust assays and Arthur recounted a 2004 visit to a pharma company using replicates in assays. conversation highlighted the importance of establishing the correct disease context, setting up appropriate assays

I then undertook my first project where I demonstrated that MRAP2 regulates the signaling of multiple MRAP2 regulates GHSR1a signaling; this project brought forth our NanoBiT-based arrestin recruitment assay This powerful tool allowed us to create an assay that kinetically measured the arrestin recruitment to I joined the lab, I became proficient in many In-vivo techniques, I adapted my arrestin recruitment assay

Discover pHSense™ portfolio From binding to signaling to internalization: Cell-based fluorescence assays This results in high sensitivity and specificity in no-wash, plate-based live-cell assays. pHSense™ Eu G-Protein Activation Quantify Gs, Gi, and Gq activation in real time with cAMP, GTP, and IP-One assays Arrestin Recruitment Detect β-arrestin recruitment with TR-FRET and luminescence assays tailored for Build Your GPCR Assay Workflow Meet the Team behind pHSense™ Eric TRINQUET Sr Director Life Sciences

INSERM with a specific interest in G protein-coupled receptors by developing original BRET and TR-FRET assays He discovered multiple rare and loss-of-function variants of the MT2 melatonin receptors that are associated

During my PhD, I learnt radioligand binding assays, behavioral assays, autoradiography, stereotaxic surgeries

GPCR Podcast Back when GPCR assays were performed with single channel pipettes, failure wasn’t cheap. Michelle Halls still remembers pipetting one sample at a time, holding her breath to keep the assay alive

Whether you’re refining assay strategy or evaluating data, these lessons give you the tools to think Yamina’s Corner—GPCR consulting to de-risk and accelerate your pipeline ♦️ Celtarys’ validated TR-FRET assay

Discover how Celtarys Research is transforming GPCR assay development with fluorescent ligands in this focus is on enabling fast, customizable development of fluorescent ligands and chemical probes for GPCR assays GPCR, Celtarys will bring those lessons to the broader community, providing insight into assay development Each probe must retain activity, remain soluble, and be compatible with a given assay format. Whether you're designing assays, developing probes, or seeking better tools for GPCR drug discovery,

His focus is on expanding commercial reach and accelerating the adoption of the company’s GPCR assay very useful in GPCR drug discovery, starting from hit and lead validation all the way to pre-clinical assays using fluorescent ligands for this are Lucía from Celtarys Research Sep 23 4 min read Optimizing HTRF Assays fluorescently labeled ligands and innovative chemical biology tools to support real-time, non-radioactive GPCR assays GPCR Functional Assay Fluorescent GTPγS enables sensitive, non-radioactive GPCR activity assays for drug

David has over 20+ years of experience working in a drug discovery environment mainly in a specialist assay His current interests include the development of HTS fluorescence-based kinetic binding assays specifically

drug discovery with predictive molecular modeling that forecasts receptor behavior—before the first assay receptor-ligand interactions after the fact; they aim to forecast receptor behavior before the first assay From Pipettes to Platforms: The Evolution of GPCR Research The first time Michelle ran a cyclic AMP assay

Khorana’s lab made early key contributions and developed strategies to express, reconstitute and assay He also went on to discover a “counterion switch” in visual pigments and to develop strategies to assay Howard Hughes Medical Institute appointment, Tom advanced a series of novel biochemical and biophysical assay

Accelerated Program Progression: Design robust assay cascades and establish key go/no-go points to speed Optimization For Contract Research Organizations Elevate Scientific Offerings: Refine and optimize your GPCR assay Define Actionable Objectives Together, we clarify specific, measurable goals, from target validation and assay Accelerated Preclinical Progression I streamline critical operational processes, from advanced assay Small missteps can derail entire programs: underperforming assays, off-track CROs, and data that fails

engagement in intact islets and neuronal circuits — insights that inform next-generation functional assay on biological context Balanced innovation with the need for reproducible, well-controlled functional assays